Emergency:
+91-124 4588 888
  • Download PHR App

Dr. Radhika Narsingdas Sarda

Dr. Radhika Narsingdas Sarda -  Infectious Disease Doctor in Gurgaon, India
Designation: Associate Consultant
Specialty :
Infectious Disease
Location :
Gurgaon
Nationality :
Indian
Languages Spoken :
English, Hindi
Total Experience (Years) :
8
Hospital :
Artemis Hospitals
Profile:

Brief bio: 

Dr Radhika Sarda is an Infectious Diseases Specialist at Artemis Hospitals, Gurugram, with over 8 years of experience. She has completed her clinical training in Internal Medicine and Infectious Diseases at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. Following this, she pursued a one-year post-doctoral fellowship in Transplant Infectious Diseases at Christian Medical College (CMC), Vellore, making her one of the few specialists in India with formal training in this subspecialty. 

Her clinical experience across both North and South India has equipped her with strong expertise in diagnosing and managing a wide spectrum of infectious diseases, including pyrexia of unknown origin, tropical infections, hospital-acquired infections, and complex infections in immunocompromised and transplant patients. 

Dr. Sarda has also undertaken observerships at Henry Ford Hospital, Detroit, USA, as well as at MGM Hospitals, Dr Rela Institute & Medical Centre, and Gleneagles Hospitals in Chennai. In addition, she has experience in adult immunisation practices and the development and implementation of infection prevention and control (IPC) protocols. 

Qualification: 

  • MBBS (Kasturba Medical College, Manipal) 
  • DM Infectious Diseases (AIIMS, New Delhi) 
  • Post-doctoral Transplant Infectious Diseases Fellowship (CMC, Vellore) 

Area of expertise:  

  • Fever of unknown origin  
  • Pre- and post-transplant infections (both hematopoietic stem cell transplants and solid organ transplants) 
  • Chemotherapy-related infections 
  • Surgical site infections  
  • Prosthetic joint infections 
  • Bone and joint infections 
  • Tuberculosis, NTM, Brucellosis  
  • HIV 
  • Tropical Infections: Malaria, Dengue, Leptospirosis, Scrub typhus, Typhoid 
  • Fungal infections 
  • Travel Medicine  
  • Adult Immunization 
  • Formulation of the hospital antibiotic policies 

Memberships: 

  • Clinical Infectious Diseases Society of India 
  • European Society of Clinical Microbiology and Infectious Diseases 
  • Transplant ID Subcommittee of India 

PUBLICATIONS: 

Systematic review and meta-analysis 

Sahni S, Gupta G, Sarda R, Pandey S, Pandey RM, Sinha S. Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis. Diabetes Metab Syndr. 2021 Nov Dec;15(6):102308. doi:10.1016/j.dsx.2021.102308. Epub 2021 Oct 

Research and Original articles: 

1. Vishwanath S, Sarda RD’souza AO, Mukhopadhyay C. Asymptomatic bacteriuria among patients with diabetes mellitus at a tertiary care center. National Journal of Laboratory Medicine. 2013 Sep;2(3):16-9. 

2. Sarda R, Kumar A, Chandra A, Bir M, Kumar S, Soneja M, Sinha S, Wig N. Prevalence of Long COVID-19 and its Impact on Quality of Life Among Outpatients With Mild COVID-19 Disease at Tertiary Care Center in North India. Journal of Patient Experience. 2022 Aug;9:23743735221117358. 

3. Sarda R, Mattoo B, Kumar A, H V, Madaan N, Wig N. Resuming outpatient services during COVID times: Our approach and experience at India's apex institute. Int J Health Plan Manage. 2021 Nov;36(6):2011-2019. doi:10.1002/hpm.3280. Epub 2021 Jul 15 

4. Chandra A, Sarda R, Kumar A, Bir M, Parija PP, Pal A, Sinha S, Vikas H, Naveet W. Impact of COVID-19 on the patients' income and work in Delhi, India. J Family Med Prim Care. 2021 Aug;10(8):3047-3050. doi:10.4103/jfmpc.jfmpc_2582_20. Epub 2021 Aug 27 

5. Swain S, Ray A, Sarda R, Vyas S, Singh G, Jorwal P, Kodan P, Khanna P, Xess I, Sinha S, Wig N, Trikha A. COVID-19-associated subacute invasive pulmonary aspergillosis. Mycoses. 2022 Jan;65(1):57-64. doi:10.1111/myc.13369. Epub 2021 Sep 29 

6. Gupta G, Shareef I, Tomar S, Kumar MSN, Pandey S, Sarda R, Singh R, Das BK, Sinha S. Th1/Th2/Th17 Cytokine Profile among Different Stages of COVID-19 Infection. Natl Acad Sci Lett. 2022;45(4):363-369.doi: 10.1007/s40009-022-01123-9. Epub 2022 May 4 

8. Keri VC, Jorwal P, Verma R, Ranjan P, Upadhyay AD, Aggarwal A, Sarda R, Sharma K, Sahni S, Rajanna C. Novel Scoring Systems to Predict the Need for Oxygenation and ICU Care, and Mortality in Hospitalised COVID-19 Patients: A Risk Stratification Tool. Cureus. 2022 Jul 29;14(7):e27459 

9. Arora U, Priyadarshi M, Katiyar V, Soneja M, Garg P, Gupta I, Bharadiya V, Berry P, Ghosh T, Patel L, Sarda R, Garg S, Agarwal S, Arora V, Ramprasad A, Kumar A, Garg RK, Kodan P, Nischal N, Singh G, Jorwal P, Kumar A, Baitha U, Meena VP, Ray A, Sethi P, Xess I, Vikram N, Sinha S, Biswas A, Thakar A, Bhatnagar S, Trikha A, Wig N. Risk factors for Coronavirus disease-associated mucormycosis. J Infect. 2022 Mar;84(3):383-390. doi:10.1016/j.jinf.2021.12.039. Epub 2021 Dec 30 

Letter to the editor: 

1. Garg P, Arora U, Kumar A, Malhotra A, Kumar S, Garg S, Arora M, Sarda R, Wig N. Risk factors for prolonged fatigue after recovery from COVID-19. J Med Virol. 2021 Apr;93(4):1926-1928. doi: 10.1002/jmv.26774. Epub 2021 Jan 12 

2. Sarda R, Swain S, Ray A, Wig N. COVID-19-associated mucormycosis: an epidemic within a pandemic. QJM. 2021 Oct 7;114(6):355-356. doi:10.1093/qjmed/hcab165 

3. Sarda R, Swain S, Ray A, Wig N. Response to: COVID-19-associatedmucormycosis and evolving evidence. QJM. 2022 Jun 7;115(6):422. doi:10.1093/qjmed/hcab191 

4. Sarda R, Ray A. TB and chronic pulmonary aspergillosis: a few relevant points. Int J Tuberc Lung Dis. 2021 Nov 1;25(11):959a-959. doi:10.5588/ijtld.21.0415 

5. Sarda R, Ray A. Pulmonary TB and chronic pulmonary aspergillosis. Int J Tuberc Lung Dis. 2021 Dec 1;25(12):1042-1043. doi: 10.5588/ijtld.21.0493 

Non indexed: 

1. Chowdhury S, Sarda R, Kumar A, Singh AK, Vikas H, Ranjan P, Wig N. Knowledge, perception, and myths about COVID-19: A study from AIIMS, New Delhi. Journal of Public Health and Primary Care. 2021 Jan 1;2(1):6-9. 

Frequently Asked Questions

How can I book an appointment with Dr. Radhika Narsingdas Sarda at Artemis Hospitals, Gurugram?

You can book an appointment through the hospital website, the Artemis PHR application, or by calling the Artemis call center at 0124-4511111.

Consultation timings for Dr. Radhika Sarda starts from 9 AM until 6 PM from Monday to Friday. Contact us to book an appointment in advance for a hassle-free experience.

Dr. Radhika Narsingdas Sarda specializes in diagnosing and managing a wide range of infectious diseases, including fever of unknown origin, tropical infections (such as malaria, dengue, and typhoid), tuberculosis, HIV, fungal infections, hospital-acquired infections, and infections in immunocompromised and transplant patients.

Yes, you can consult Dr. Radhika Narsingdas Sarda for a second opinion on infectious disease-related concerns. Please contact the hospital or use the Artemis PHR app to schedule your appointment.

Yes, she offers both in-person and teleconsultation services. Kindly contact the hospital to schedule your preferred mode of consultation.

You should bring all relevant medical records, including previous prescriptions, diagnostic reports, vaccination history, travel history (if applicable), and details of any ongoing treatments to help ensure an accurate diagnosis and effective treatment plan.

The consultation charges for Dr. Radhika Sarda are Rs. 1300/-.

For emergency cases, patients are advised to visit the emergency department at Artemis Hospitals, Gurugram. Availability for urgent consultations with Dr. Sarda may vary.

Yes, Dr. Radhika Narsingdas Sarda treats adult and elderly patients with a wide range of infectious diseases. To schedule an appointment with her, get in touch with us for a hassle-free experience.

Yes, she has expertise in managing chronic infections such as HIV, hepatitis, and other long-term infectious conditions, offering comprehensive evaluation, treatment, and follow-up care.

World Of Artemis

Artemis Hospitals, established in 2007, is a healthcare venture launched by the promoters of the 4$ Billion Apollo Tyres Group. It is spread across a total area of 525,000 square feet.

To know more
For any inquiries, appointment bookings, or general concerns, reach us at contactus@artemishospitals.com.
For International Patient Services, reach us at internationaldesk@artemishospitals.com.
For any feedback-related issues, reach us at feedback@artemishospitals.com.

Request a call back


Get Direction